View Older Stories View More Recent Stories

Aug 13, 2026 04:06PM Form SCHEDULE 13G/A Hyatt Hotels Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G Dianthus Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G/A Heartflow, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G RENASANT CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G Forbright, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G/A Jefferson Capital, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G/A NORTHPOINTE BANCSHARES Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G/A NXP Semiconductors N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 04:06PM Form SCHEDULE 13G/A Innovex International, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 13, 2026 06:59AM H.C. Wainwright Reiterates Buy Rating on NextCure Inc. (NXTC)
Aug 10, 2026 07:01AM Avere Therapeutics raises $500M in private placement for drug program
Aug 10, 2026 07:00AM Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001
Aug 6, 2026 10:42AM Form SCHEDULE 13G/A First Western Financial Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 6, 2026 10:42AM Form SCHEDULE 13G/A MNTN, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 6, 2026 10:42AM Form SCHEDULE 13G/A Heartflow, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 6, 2026 10:42AM Form SCHEDULE 13G/A TREX CO INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 6, 2026 10:42AM Form SCHEDULE 13G/A REDWOOD TRUST INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 6, 2026 10:42AM Form SCHEDULE 13G/A National Vision Holdings Filed by: WELLINGTON MANAGEMENT GROUP LLP
Aug 6, 2026 07:02AM Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing
Aug 6, 2026 07:02AM Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Aug 5, 2026 10:30AM Franklin Templeton names new product and Asia Pacific heads
Aug 5, 2026 10:30AM Franklin Templeton Expands Global Client Group Leadership to Accelerate Next Phase of Growth
Aug 4, 2026 11:36AM Form D/A Wellington Management
Aug 3, 2026 09:00AM Obsidian Therapeutics completes Galera merger, raises $350M
Aug 3, 2026 09:00AM Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million
Jul 29, 2026 07:00AM Synlogic and Caldera Therapeutics agree to all-stock merger
Jul 29, 2026 07:00AM Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement
Jul 27, 2026 02:15AM Emerging markets stare at inflation risks as powerful El Niño looms
Jul 22, 2026 09:00AM Lumafield Introduces Mars In-line Arrayed X-ray System for 100% Production Inspection
Jul 22, 2026 08:47AM Wellington, Vanguard, Blackstone launch funds targeting wealthy investors
Jul 22, 2026 08:46AM Wellington, Vanguard, and Blackstone launch two public-private funds
Jul 22, 2026 08:45AM Wellington, Vanguard, and Blackstone Announce the Launch of Two Investment Solutions, Simplifying Access to Public and Private Markets
Jul 22, 2026 08:00AM Crystalys Therapeutics Announces $130 Million Series B Financing to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout
Jul 21, 2026 04:01PM EXL adds former KPMG UK chair to board, names new lead director
Jul 21, 2026 04:01PM EXL announces appointment of Bina Mehta to Board of Directors and lead director transition
Jul 15, 2026 12:30PM FalconX Acquires bloXroute to Accelerate the Future of Onchain Capital Markets
Jul 14, 2026 06:01AM NextCure and Avere to merge, targeting oral IL-23 therapy
Jul 14, 2026 06:00AM NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
Jul 8, 2026 12:59PM Form SCHEDULE 13G/A Excelerate Energy, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Jul 8, 2026 12:59PM Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Jul 8, 2026 12:59PM Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Jul 8, 2026 12:59PM Form SCHEDULE 13G/A US Foods Holding Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Jul 8, 2026 08:30AM Eagle Energy Partners Appoints Institutional Capital Markets Veteran Daniel Fugiel to Board of Directors
Jul 8, 2026 02:24AM Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
Jul 7, 2026 08:00AM FORE Biotherapeutics Announces Closing of Upsized $67.4 Million Series D-2 Extension Financing and Highlights Recent Plixorafenib Achievements
Jul 1, 2026 01:53PM Form D/A Wellington Management
Jun 30, 2026 04:23PM JOHN HANCOCK DIVERSIFIED INCOME FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
Jun 30, 2026 09:36AM Higharc Raises $95M Series C to Scale AI for Homebuilding
View More Recent Stories View Older Stories